Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Motor Activity 1Lymphoma, Follicular 1Colitis, Ulcerative 1

Interventions

Exercise 12Methods 2Diet 2Behavior Therapy 2secukinumab 1peficitinib 1lime 1cytisine 1Waiting Lists 1Telemedicine 1Spirometry 1Self-Management 1Resistance Training 1Professional Autonomy 1Nutrition Assessment 1Metformin 1Memantine 1High-Intensity Interval Training 1Hematologic Tests 1Health 1Exergaming 1Diet Therapy 1Counseling 1Clinical Trials as Topic 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Motor Activity × peficitinib × Clear all
NCT01959282 2019-01-04

A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis

Janssen Research & Development, LLC

Phase 2 Completed
219 enrolled
Lymphoid

Colitis, Ulcerative, Lymphoma, Follicular, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡